Paracelsus Medizinische Privatuniversität (PMU)

Research & Innovation
Publications

HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer

#2021
#Cancers

PMU Authors
Christian Reinhard Mayr, Tobias Kiesslich, Dino Bekric, Heidemarie Dobias, Marlena Beyreis, Markus Ritter, Tarkan Jäger, Bettina Neumayer, Eckhard Klieser, Daniel Neureiter

All Authors
Christian Reinhard Mayr, Tobias Kiesslich, Sara Erber, Dino Bekric, Heidemarie Dobias, Marlena Beyreis, Markus Ritter, Tarkan Jäger, Bettina Neumayer, Paul Winkelmann, Eckhard Klieser, Daniel Neureiter

Journal association
Cancers

Abstract

Keywords

EXPRESSION, STEM-CELLS, GROWTH, PROLIFERATION, CARCINOMA-CELL-LINE, ESTABLISHMENT, CHOLANGIOCARCINOMA, HISTONE DEACETYLASE INHIBITOR, TRICHOSTATIN, DEPSIPEPTIDE